Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
Abbott, Timothy R., Dhamdhere, Girija, Liu, Yanxia, Lin, Xueqiu, Goudy, Laine, Zeng, Leiping, Chemparathy, Augustine, Chmura, Stephen, Heaton, Nicholas S., Debs, Robert, Pande, Tara, Endy, Drew, La Russa, Marie F., Lewis, David B., Qi, Lei S.
Published in Cell (14.05.2020)
Published in Cell (14.05.2020)
Get full text
Journal Article
Web Resource
A comprehensive analysis and resource to use CRISPR-Cas13 for broad-spectrum targeting of RNA viruses
Lin, Xueqiu, Liu, Yanxia, Chemparathy, Augustine, Pande, Tara, La Russa, Marie, Qi, Lei S.
Published in Cell reports. Medicine (20.04.2021)
Published in Cell reports. Medicine (20.04.2021)
Get full text
Journal Article
RNA language models predict mutations that improve RNA function
Shulgina, Yekaterina, Trinidad, Marena I, Langeberg, Conner J, Nisonoff, Hunter, Chithrananda, Seyone, Skopintsev, Petr, Nissley, Amos J, Patel, Jaymin, Boger, Ron S, Shi, Honglue, Yoon, Peter H, Doherty, Erin E, Pande, Tara, Iyer, Aditya M, Doudna, Jennifer A, Cate, Jamie H D
Published in bioRxiv : the preprint server for biology (06.04.2024)
Get more information
Published in bioRxiv : the preprint server for biology (06.04.2024)
Journal Article
Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza
Abbott, Timothy R, Dhamdhere, Girija, Liu, Yanxia, Lin, Xueqiu, Goudy, Laine E, Zeng, Leiping, Chemparathy, Augustine, Chmura, Stephen, Heaton, Nicholas, Debs, Robert, Pande, Tara, Endy, Drew, Marie La Russa, Lewis, David B, Qi, Lei S
Published in bioRxiv (14.03.2020)
Published in bioRxiv (14.03.2020)
Get full text
Paper